Life-Saving Drug Donated to Daniel Carl Torsch Foundation

Ammon Labs, the preferred drug testing laboratory by addiction treatment professionals and healthcare partners for over 20 years, and The Choopers Foundation, a non-profit organization committed to elevating awareness of addiction as a disease, donated 200 doses of the opioid overdose reversal medication Naloxone to The Daniel Carl Torsch (DCT) Foundation. The presentation was made at the National Council on Alcoholism and Drug Dependence (NCADD) of Maryland Tuerk Conference in Baltimore on April 19th.

Like much of the country, the state of Maryland is currently grappling with the gravest public health crisis of the modern era. It is estimated that there are over 20,000 estimated active heroin users in the city of Baltimore and thousands of others struggling with opioid addiction across the state. Since 2015, Maryland has seen a drastic increase in the number of overdoses, making the need for life-saving treatments like Naloxone even more necessary. Unfortunately, the high demand for Naloxone has created a statewide shortage that has prevented many from receiving the medication when they desperately need it.

“We make a commitment to regularly meet with the community organizations leading the fight against opioid abuse in each state where we conduct drug testing. In our conversations with the DCT Foundation, The Choopers Foundation and NCADD Maryland, we were alerted to Maryland’s current statewide Naloxone shortage,” said Charles Cardona, VP of Business Development for Ammon Labs. “Although we hope for a day when Naloxone will not be a necessity in the medicine cabinets of families coping with the addiction of a loved one, we recognize that Ammon Labs is in a unique position to provide direct assistance to these organizations and provide them with a lifesaving resource.”

The Daniel Carl Torsch Foundation was founded by Carl and Toni Torsch following the overdose death of their son, Daniel, in 2010. Authorized by the Department of Health & Mental Hygiene of Maryland, The DCT Foundation conducts an educational training program (Overdose Response Program ORP) using a core curriculum that includes information and training on: prescription and non-pharmaceutical opioids, how to recognize and respond to an opioid overdose, proper rescue breathing technique, and how to properly administer Naloxone and care for the individual until emergency medical help arrives. The donation of 200 doses of Naloxone will enable the Foundation to provide additional potentially life-saving training to families and friends struggling with the opioid addiction of a loved one.

Tim Cheney, President of The Choopers Foundation added, “Part of ending the stigma surrounding opioid abuse, is ensuring that Naloxone is readily available to those who need it. Through helping to ensure access to this medication in Maryland, we are hoping to stem the tide of opioid overdoses currently ravaging the state and create an atmosphere where those who need help with an addiction can find it.”

To learn more about Ammon Labs and the science behind addiction treatment, visit www.ammonlabs.com. For the latest news and updates, follow Ammon Labs on Facebook(https://www.facebook.com/Ammonsince1998/), Twitter (@AmmonLabs), Instagram (@ammonlabs), and LinkedIn (https://www.linkedin.com/company/10867833/).

About Ammon Labs

Family owned and operated, Ammon Labs has been the preferred drug testing laboratory of addiction treatment professionals and healthcare partners for over 20 years. Backed by the nation’s leading scientists, Ammon Labs is an innovator in toxicology, clinical blood and genetics testing. Specializing in personalized, targeted solutions for healthcare partners, Ammon Labs provides quality services and competitive pricing. Through a commitment to compliance and responsible testing, Ammon Labs is a dedicated partner in the fight against opioid abuse, providing the tools necessary to empower addiction treatment professionals and make a positive impact in the lives of those suffering from addiction.

About The Choopers Foundation

The Choopers Foundation is the philanthropic endeavor of Chooper’s Guide, a comprehensive addiction treatment and information resource. Founded by Timothy Cheney and Adrian S. Hooper, Jr. in 2015, the Foundation’s primary objectives are to elevate awareness of addiction as a disease, promote social justice, influence drug policy and to educate providers and the public.

The Choopers Foundation provides financial assistance to harm reduction and recovery community initiatives and focuses on innovative projects and programs that address the needs of the underserved. More information about The Choopers Foundation can be found by visiting http://choopersfoundation.org/ .